Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?

被引：3
|
作者：
Einhorn, Lawrence H. [1 ,2 ]
Abonour, Rafat [1 ]
Kesler, Kenneth A.
机构：
[1] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Lance Armstrong Fdn Chair Oncol, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 35期
关键词：
EXPERIENCE; POSTCHEMOTHERAPY;
D O I：
10.1200/JCO.2010.30.4626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E739 / E739
页数：1
相关论文
共 50 条
  • [31] Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors
    Feldman, Darren R.
    Glezerman, Ilya
    Patil, Sujata
    Van Alstine, Lindsay
    Bajorin, Dean F.
    Fischer, Patricia
    Hughes, Amanad
    Sheinfeld, Joel
    Bains, Manjit
    Reich, Lilian
    Woo, Kaitlin
    Giralt, Sergio
    Bosl, George J.
    Motzer, Robert J.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : 453 - 460
  • [32] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
    Darren R Feldman
    Robert J Motzer
    Dean F Bajorin
    Nature Clinical Practice Urology, 2008, 5 : 78 - 79
  • [33] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
    Feldman, Darren R.
    Motzer, Robert J.
    Bajorin, Dean F.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (02): : 78 - 79
  • [34] Salvage therapy with high-dose chemotherapy (HDCT) and peripheral blood stem cell transplant (PBSCT) in patients with primary mediastinal nonseminomatous germ cell tumors (PMNSGCT).
    Asirwa, F. C.
    Einhorn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Feldman, D. R.
    Sheinfeld, J.
    Bajorin, D. F.
    Fischer, P.
    Turkula, S.
    Ishill, N.
    Patil, S.
    Bains, M.
    Bosl, G. J.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function
    Shiraishi, Takumi
    Nakamura, Terukazu
    Takamura, Toshiya
    Oishi, Masakatsu
    Yamada, Takeshi
    Yamada, Yasuhiro
    Ueda, Takashi
    Fujihara, Atsuko
    Hongo, Fumiya
    Okihara, Koji
    Ukimura, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (02) : 134 - 139
  • [37] HIGH-DOSE TREATMENT WITH CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY GERM-CELL CANCER - A PHASE I/II STUDY
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    BAURMANN, H
    OETTLE, H
    ZINGSEM, J
    ZIMMERMANN, R
    BOKEMEYER, C
    SCHMOLL, HJ
    HUHN, D
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1223 - 1231
  • [38] Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer
    Minichmayr, Iris
    Nock, Valerie
    Jaehde, Ulrich
    Kloft, Charlotte
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 74 - 76
  • [39] SALVAGE THERAPY WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT IN THE TREATMENT OF PRIMARY NONSEMINOMATOUS MEDIASTINAL GERM-CELL TUMORS
    BROUN, ER
    NICHOLS, CR
    EINHORN, LH
    TRICOT, GJK
    CANCER, 1991, 68 (07) : 1513 - 1515
  • [40] High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
    Richardson, Noah H.
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad
    Hanna, Nassar H.
    Kesler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    CANCER, 2024, 130 (18) : 3115 - 3122
12345